Amphotericin B Zentiva 50 mg, Pulver zur Herstellung einer Infusionsdispersion (i.v.)

7680701770018 CH-70177 Pulver

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
amphotericinum B
50.0 MG Substance Wirkstoff (Principe actif)
phosphatidylcholinum ex soja hydrogenatum
- Substance HNIDK
distearoylphosphatidylglycerolum natricum
- Substance HNIDK
cholesterolum
- Substance HNIDK
int-rac-alpha-tocopherolum
- Substance HNIDK
saccharum
- Substance HNIDK
dinatrii succinas hexahydricus
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
70177
Drug name
Amphotericin B Zentiva, Pulver zur Herstellung einer Infusionsdispersion (i.v.)
Galenic form
PULVID
ATC Code
J02AA01
Authorization status
Z
Dispensing category
A
First authorization
03/03/2026
Authorization expiration date
02/03/2031
IT Number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Package details

Description (FR)
AMPHOTERICIN B Zentiva subst seche 50 mg 1 pce
Description (DE)
AMPHOTERICIN B Zentiva Trockensub 50 mg 1 Stk
Market launch
01/10/2026
Narcotic (BTM)
No

Other package sizes (1)

AMPHOTERICIN B Zentiva subst seche 50 mg 10 pce
10 DUR
GTIN: 7680701770025
View
Buy us a coffee Explore the data